CLL update from ICML17: Current treatment and future directions for patients
Looking beyond the leukemic cell for answers
Christopher Pepper et al.
Bendamustine plus rituximab vs. standard therapy for advanced CLL
Finding the expansion balance: CAR T-cell response markers identified from the trial of JCAR017
How the removal of macrophages from tissue can stop or slow down the progression of CLL